Magnetic Resonance Spectroscopy in Schizophrenia: Evidence for Glutamatergic Dysfunction and Impaired Energy Metabolism.

Magnetic Resonance Spectroscopy in Schizophrenia: Evidence for Glutamatergic Dysfunction and Impaired Energy Metabolism.
复制标题

DOI:
10.1007/s11064-018-2521-z
复制
发表时间:
2019-01
影响因子:
4.4
通讯作者:
Xin L
Xin L
中科院分区:
医学3区
文献类型:
--
作者:
Duarte JMN;Xin L

文献摘要

参考文献

被引文献

相似文献

在过去的几十年中,人们在提高磁共振方法代谢评估的可靠性方面做出了重大努力。磁共振波谱 (MRS) 对于提供体内证据和研究神经精神疾病(即精神分裂症)的生物标志物非常有价值。精神分裂症患者大脑中谷氨酸和谷氨酰胺水平相对于健康受试者的改变通常被解释为谷氨酸能功能障碍的标志。然而,只有一小部分可通过 MRS 检测到的谷氨酸参与神经传递。在这里,我们回顾并讨论涉及谷氨酸并且可能与神经精神疾病有关的大脑代谢过程。
In the past couple of decades, major efforts were made to increase reliability of metabolic assessments by magnetic resonance methods. Magnetic resonance spectroscopy (MRS) has been valuable for providing in vivo evidence and investigating biomarkers in neuropsychiatric disorders, namely schizophrenia. Alterations of glutamate and glutamine levels in brains of schizophrenia patients relative to healthy subjects are generally interpreted as markers of glutamatergic dysfunction. However, only a small fraction of MRS-detectable glutamate is involved in neurotransmission. Here we review and discuss brain metabolic processes that involve glutamate and that are likely to be implicated in neuropsychiatric disorders.
DOI: 10.1016/j.biopsych.2011.11.006
发表时间: 2012-06-01
影响因子: 10.6
作者:
Chowdhury, Golam M. I.;Behar, Kevin L.;Cho, William;Thomas, Monique A.;Rothman, Douglas L.;Sanacora, Gerard
通讯作者: Sanacora, Gerard
DOI: 10.1038/mp.2009.121
发表时间: 2010-06
影响因子: 11
作者:
通讯作者: --
DOI: 10.1016/j.schres.2009.07.025
发表时间: 2010-03
影响因子: 4.5
作者:
Bauer, Deborah;Haroutunian, Vahram;Meador-Woodruff, James H.;McCullumsmith, Robert E.
通讯作者: McCullumsmith, Robert E.
DOI: 10.3389/fnins.2016.00202
发表时间: 2016
影响因子: 4.3
作者:
Cariaga-Martinez A;Saiz-Ruiz J;Alelú-Paz R
通讯作者: Alelú-Paz R
DOI: 10.1038/sj.npp.1300559
发表时间: 2005-01-01
影响因子: 7.6
作者:
Bergeron, R;Coyle, JT;Greene, RW
通讯作者: Greene, RW